Maxim initiated coverage of Evaxion Biotech (EVAX) with a Buy rating and $10 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVAX:
- Evaxion Extends AI-Immunology Platform to Autoimmune Diseases and Sets 2026 Milestones
- Evaxion Biotech expands AI-Immunology platform into autoimmune diseases
- Evaxion to Outline 2026 Milestones at Biotech Showcase in San Francisco